Distrobird — Free Sales Engagement Platform
Sequences, cloud call center, shared inbox, form tracking and more — on a single platform. Double your sales team's output with fewer tools.
Create a sequence — it's free
Xonovo Ltd.
xonovo is a preclinical-stage biopharmaceutical company engaged in the development of proprietary small molecules for the treatment of neurodegenerative diseases. xonovo’s objective is to provide a first-in-class therapeutic for preventing the progressive loss of neuronal function across multiple neurodegenerative diseases. our short-term focus is a brisk preclinical program to support investigational new drug (ind) filing for batten disease [bd] (also known as neuronal ceroid lipofuscinoses; ncl), a fatal neurodegenerative orphan disorder, leveraging recent fda regulations, for accelerated ind approval process for orphan diseases. xonovo utilizes a revolutionary approach of selective modulation of autophagy and axonal transport machinery in neurons. xonovo’s technology has been extensively tested in both in vitro and in vivo models, showing promising results in neurodegenerative diseases including alzheimer, muscular dystrophy, tuberos sclerosis, and bd. xonovo’s preparatory focus is
Frequently asked questions about Xonovo Ltd.
Let us help answer the most common questions you might have.
Where is Xonovo Ltd. located?
Xonovo Ltd.'s headquarters is located at Israel
What is Xonovo Ltd.'s official website?
Xonovo Ltd.'s official website is xonovo.com
What is Xonovo Ltd.'s SIC code?
How many employees does Xonovo Ltd. have?
Xonovo Ltd. has 1 employee
What industry does Xonovo Ltd. belong to?
Xonovo Ltd. is in the industry of: Biotechnology
What are Xonovo Ltd.'s social media links?
Xonovo Ltd. Linkedin page
Distrobird — Free Sales Engagement Platform
Sequences, cloud call center, shared inbox, form tracking and more — on a single platform. Double your sales team's output with fewer tools.
Create a sequence — it's free